Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A refined experimental model for proliferative vitreoretinopathy.

D B Chandler, F A Quansah, T Hida

    Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie
    |January 1, 1986
    PubMed
    Summary

    A new animal model for proliferative vitreoretinopathy (PVR) uses compressed vitreous and fewer fibroblasts. This refined model accurately mimics human PVR, causing retinal detachments effectively.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer.

    ESMO open·2022
    Same author

    Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non-small-cell lung cancer: The global, multicenter EXPRESS study.

    Lung cancer (Amsterdam, Netherlands)·2019
    Same author

    A case of childhood-onset cutaneous mastocytosis with loss of wild-type KIT allele.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study.

    European journal of cancer (Oxford, England : 1990)·2018
    Same author

    Granulocyte colony-stimulating factor-producing melanoma treated with the combination of dabrafenib and trametinib.

    International journal of dermatology·2018

    Area of Science:

    • Ophthalmology
    • Retinal Diseases
    • Cell Biology

    Background:

    • Current animal models for proliferative vitreoretinopathy (PVR) using intact vitreous and numerous fibroblasts do not accurately reflect human disease.
    • The need for a more accurate and efficient PVR model is critical for understanding disease mechanisms and testing therapies.

    Purpose of the Study:

    • To develop a refined animal model of proliferative vitreoretinopathy (PVR).
    • To investigate if a partially detached vitreous with fewer fibroblasts can effectively induce PVR and retinal detachment.

    Main Methods:

    • A novel PVR model was created by compressing and partially detaching the vitreous using intravitreal perfluoropropane injection.
    • Subsequently, 25,000 homologous fibroblasts were injected into the vitreous cavity.

    Related Experiment Videos

  • The model was evaluated for fibroblast proliferation and induction of retinal detachment.
  • Main Results:

    • Fibroblast proliferation was observed primarily on the retinal surface in the refined model.
    • Retinal detachments occurred with a frequency comparable to existing models that use significantly larger numbers of cells.
    • This indicates the model's efficacy in simulating key aspects of human PVR.

    Conclusions:

    • The refined PVR model, utilizing a partially detached vitreous and a reduced cell count, offers a more accurate and potentially more efficient representation of human PVR.
    • This model facilitates the study of PVR pathogenesis and the evaluation of therapeutic interventions.